ReP USP - Resultado da busca

Artigo de periodico
Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile (2023)
Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Sieczkowska, Sofia Mendes ; Romero, Marina; Ribeiro, Thaina Toledo; Amarante, Milla Cordeiro ; Pasoto, Sandra G ; Pinto, Ana Lúcia de Sá ; Lima, Fernanda Rodrigues; Benatti, Fabiana B ; Bonfa, Eloisa Silva Dutra de Oliveira ; Roschel, Hamilton ; Gualano, Bruno
Source: Lupus. Unidades: FM, EEFE, EE
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, QUALIDADE DE VIDA, SAÚDE MENTAL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZZOLANI, Bruna Caruso et al. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile. Lupus, v. 32, n. 11, p. 1287-1295, 2023Tradução . . Disponível em: https://doi.org/10.1177/096120332312025. Acesso em: 06 jun. 2024.
APA
Mazzolani, B. C., Smaira, F. I., Sieczkowska, S. M., Romero, M., Ribeiro, T. T., Amarante, M. C., et al. (2023). Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile. Lupus, 32( 11), 1287-1295. doi:10.1177/09612033231202582
NLM
Mazzolani BC, Smaira FI, Sieczkowska SM, Romero M, Ribeiro TT, Amarante MC, Pasoto SG, Pinto AL de S, Lima FR, Benatti FB, Bonfa ESD de O, Roschel H, Gualano B. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile [Internet]. Lupus. 2023 ; 32( 11): 1287-1295.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/096120332312025
Vancouver
Mazzolani BC, Smaira FI, Sieczkowska SM, Romero M, Ribeiro TT, Amarante MC, Pasoto SG, Pinto AL de S, Lima FR, Benatti FB, Bonfa ESD de O, Roschel H, Gualano B. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile [Internet]. Lupus. 2023 ; 32( 11): 1287-1295.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/096120332312025
Artigo de periodico
Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus (2023)
Silva Neto, Epitacio Dias da ; Rodrigues Neto, Taurino dos Santos ; Signorelli, Flavio Victor; Balbi, Gustavo Guimaraes Moreira ; Higashi, Alex Haruo; Monteiro, Mario Luiz Ribeiro ; Bonfa, Eloisa Silva Dutra de Oliveira ; Andrade, Danieli Castro Oliveira de ; Zacharias, Leandro Cabral
Source: Clinical rheumatology. Unidade: FM
Subjects: RETINA, LÚPUS ERITEMATOSO SISTÊMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA NETO, Epitacio Dias da et al. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clinical rheumatology, v. 42, n. 8, p. 2105-2114, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54727. Acesso em: 06 jun. 2024.
APA
Silva Neto, E. D. da, Rodrigues Neto, T. dos S., Signorelli, F. V., Balbi, G. G. M., Higashi, A. H., Monteiro, M. L. R., et al. (2023). Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clinical rheumatology, 42( 8), 2105-2114. doi:10.1007/s10067-023-06613-9
NLM
Silva Neto ED da, Rodrigues Neto T dos S, Signorelli FV, Balbi GGM, Higashi AH, Monteiro MLR, Bonfa ESD de O, Andrade DCO de, Zacharias LC. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus [Internet]. Clinical rheumatology. 2023 ; 42( 8): 2105-2114.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54727
Vancouver
Silva Neto ED da, Rodrigues Neto T dos S, Signorelli FV, Balbi GGM, Higashi AH, Monteiro MLR, Bonfa ESD de O, Andrade DCO de, Zacharias LC. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus [Internet]. Clinical rheumatology. 2023 ; 42( 8): 2105-2114.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54727
Artigo de periodico
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition (2023)
Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Ribeiro, Ana Cristina Medeiros ; Pasoto, Sandra Gofinet ; Saad, Carla Goncalves Schahin ; Yuki, Emily Figueiredo Neves ; Landim, Joaquim Ivo Vasques Dantas ; Leda, Victor Hugo Ferreira e; Correia, Luisa Sacchi de Camargo ; Sartori, Artur Fonseca ; Shinjo, Samuel Katsuyuki ; Borba Neto, Eduardo Ferreira ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Advances in rheumatology. Unidade: FM
Subjects: COVID-19, VACINAÇÃO, DOENÇAS REUMÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Clovis Artur Almeida da et al. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition. Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54760. Acesso em: 06 jun. 2024.
APA
Silva, C. A. A. da, Kupa, L. de V. K., Ribeiro, A. C. M., Pasoto, S. G., Saad, C. G. S., Yuki, E. F. N., et al. (2023). Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition. Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00309-z
NLM
Silva CAA da, Kupa L de VK, Ribeiro ACM, Pasoto SG, Saad CGS, Yuki EFN, Landim JIVD, Leda VHF e, Correia LS de C, Sartori AF, Shinjo SK, Borba Neto EF, Bonfa ESD de O. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54760
Vancouver
Silva CAA da, Kupa L de VK, Ribeiro ACM, Pasoto SG, Saad CGS, Yuki EFN, Landim JIVD, Leda VHF e, Correia LS de C, Sartori AF, Shinjo SK, Borba Neto EF, Bonfa ESD de O. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54760
Artigo de periodico
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition (2023)
Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Ribeiro, Ana Cristina Medeiros ; Pasoto, Sandra Gofinet ; Saad, Carla Goncalves Schahin ; Yuki, Emily Figueiredo Neves ; Landim, Joaquim Ivo Vasques Dantas ; Leda, Victor Hugo Ferreira e; Correia, Luisa Sacchi de Camargo ; Sartori, Artur Fonseca ; Shinjo, Samuel Katsuyuki ; Borba Neto, Eduardo Ferreira ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Advances in rheumatology. Unidade: FM
Subjects: COVID-19, VACINAÇÃO, DOENÇAS REUMÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Clovis Artur Almeida da et al. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition. Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54760. Acesso em: 06 jun. 2024.
APA
Silva, C. A. A. da, Kupa, L. de V. K., Ribeiro, A. C. M., Pasoto, S. G., Saad, C. G. S., Yuki, E. F. N., et al. (2023). Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition. Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00309-z
NLM
Silva CAA da, Kupa L de VK, Ribeiro ACM, Pasoto SG, Saad CGS, Yuki EFN, Landim JIVD, Leda VHF e, Correia LS de C, Sartori AF, Shinjo SK, Borba Neto EF, Bonfa ESD de O. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54760
Vancouver
Silva CAA da, Kupa L de VK, Ribeiro ACM, Pasoto SG, Saad CGS, Yuki EFN, Landim JIVD, Leda VHF e, Correia LS de C, Sartori AF, Shinjo SK, Borba Neto EF, Bonfa ESD de O. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54760
Artigo de periodico
In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) (2022)
Bonfa, Eloisa Silva Dutra de Oliveira ; Sampaio-Barros, Percival
Source: Advances in rheumatology. Unidade: FM
Subjects: REUMATOLOGIA, BIOGRAFIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONFA, Eloisa Silva Dutra de Oliveira e SAMPAIO-BARROS, Percival. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022). Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50377. Acesso em: 06 jun. 2024.
APA
Bonfa, E. S. D. de O., & Sampaio-Barros, P. (2022). In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022). Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00272-1
NLM
Bonfa ESD de O, Sampaio-Barros P. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50377
Vancouver
Bonfa ESD de O, Sampaio-Barros P. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50377
Artigo de periodico
2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus (2022)
Insfran, Carlos E; Aikawa, Nadia E; Pasoto, Sandra G; Filho, Dilson M. N; Formiga, Francisco F. C; Pitta, Ana C; Borba Neto, Eduardo Ferreira ; Ribeiro, Carolina T; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Clinical rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, MULHERES 2LARPCAL, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
INSFRAN, Carlos E et al. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, v. 41, n. 4, p. 1079-1085, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10067-021-05989-w. Acesso em: 06 jun. 2024.
APA
Insfran, C. E., Aikawa, N. E., Pasoto, S. G., Filho, D. M. N., Formiga, F. F. C., Pitta, A. C., et al. (2022). 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, 41( 4), 1079-1085. doi:10.1007/s10067-021-05989-w
NLM
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Vancouver
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Artigo de periodico
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (2022)
Araujo, Carlo Scognamiglio Renner; Medeiros-Ribeiro, Ana Cristina; Saad, Carla G. S; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Kupa, Leonard de Vinci Kanda ; Pereira, Rosa Maria Rodrigues ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: METOTREXATO, VACINAS VIRAIS, ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Carlo Scognamiglio Renner et al. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, v. 81, n. 6, p. 889-897, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221916. Acesso em: 06 jun. 2024.
APA
Araujo, C. S. R., Medeiros-Ribeiro, A. C., Saad, C. G. S., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., et al. (2022). Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 81( 6), 889-897. doi:10.1136/annrheumdis-2021-221916
NLM
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Vancouver
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Artigo de periodico
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
Medeiros-Ribeiro, Ana Cristina; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Silva, Henrique Carrico da; Saad, Carla G. S.; Yuki, Emily Figueiredo Neves; Pasoto, Sandra Gofinet; Araujo, Carlo Scognamiglio Renner; Nakai, Tatiane Lie; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 06 jun. 2024.
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Artigo de periodico
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome (2022)
Signorelli, Flavio; Balbi, Gustavo Guimaraes Moreira; Aikawa, Nadia E; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Medeiros-Ribeiro, Ana C; Yuki, Emily F. N; Pasoto, Sandra G; Saad, Carla G. S; Borba Neto, Eduardo Ferreira ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Lupus. Unidade: FM
Subjects: COVID-19, ANTICORPOS ANTIFOSFOLIPÍDEOS, IMUNOGENÉTICA, FATORES DE RISCO, COAGULAÇÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIGNORELLI, Flavio et al. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus, v. 31, n. 8, p. 974-984, 2022Tradução . . Disponível em: https://doi.org/10.1177/09612033221102073. Acesso em: 06 jun. 2024.
APA
Signorelli, F., Balbi, G. G. M., Aikawa, N. E., Silva, C. A. A. da, Kupa, L. de V. K., Medeiros-Ribeiro, A. C., et al. (2022). Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus, 31( 8), 974-984. doi:10.1177/09612033221102073
NLM
Signorelli F, Balbi GGM, Aikawa NE, Silva CAA da, Kupa L de VK, Medeiros-Ribeiro AC, Yuki EFN, Pasoto SG, Saad CGS, Borba Neto EF, Bonfa ESD de O. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome [Internet]. Lupus. 2022 ; 31( 8): 974-984.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/09612033221102073
Vancouver
Signorelli F, Balbi GGM, Aikawa NE, Silva CAA da, Kupa L de VK, Medeiros-Ribeiro AC, Yuki EFN, Pasoto SG, Saad CGS, Borba Neto EF, Bonfa ESD de O. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome [Internet]. Lupus. 2022 ; 31( 8): 974-984.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/09612033221102073
Artigo de periodico
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease (2022)
Lang, Maria Grabriela; Vinagre, Carmen G C; Bonfa, Eloisa Silva Dutra de Oliveira ; Freitas, Fatima R; Pasoto, Sandra Gofinet ; Brito, Tatiane S; Seguro, Luciana P. C; Maranhão, Raul Cavalcante ; Borba, Eduardo F
Source: Lupus. Unidades: FM, FCF
Subjects: COLESTEROL, LIPOPROTEÍNAS, LÚPUS ERITEMATOSO SISTÊMICO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANG, Maria Grabriela et al. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, v. 31, n. 6, p. 659-665, 2022Tradução . . Disponível em: https://doi.org/10.1177/09612033221090127. Acesso em: 06 jun. 2024.
APA
Lang, M. G., Vinagre, C. G. C., Bonfa, E. S. D. de O., Freitas, F. R., Pasoto, S. G., Brito, T. S., et al. (2022). Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, 31( 6), 659-665. doi:10.1177/09612033221090127
NLM
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/09612033221090127
Vancouver
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1177/09612033221090127
Artigo de periodico
Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity (2022)
Pasoto, Sandra Gofinet; Halpern, Ari Stiel Radu; Guedes, Lissiane Karine Noronha; Ribeiro, Ana Cristina Medeiros; Yuki, Emily Neves Figueiredo; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Leon, Elaine Pires ; Bispo, Fabiana Renata Soares; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Clinical rheumatology. Unidade: FM
Subjects: VACINAS VIRAIS, COVID-19, DOENÇAS AUTOIMUNES, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASOTO, Sandra Gofinet et al. Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity. Clinical rheumatology, v. 41, n. 7, p. 2079-2089, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10067-022-06134-x. Acesso em: 06 jun. 2024.
APA
Pasoto, S. G., Halpern, A. S. R., Guedes, L. K. N., Ribeiro, A. C. M., Yuki, E. N. F., Silva, C. A. A. da, et al. (2022). Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity. Clinical rheumatology, 41( 7), 2079-2089. doi:10.1007/s10067-022-06134-x
NLM
Pasoto SG, Halpern ASR, Guedes LKN, Ribeiro ACM, Yuki ENF, Silva CAA da, Kupa L de VK, Leon EP, Bispo FRS, Bonfa ESD de O. Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity [Internet]. Clinical rheumatology. 2022 ; 41( 7): 2079-2089.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s10067-022-06134-x
Vancouver
Pasoto SG, Halpern ASR, Guedes LKN, Ribeiro ACM, Yuki ENF, Silva CAA da, Kupa L de VK, Leon EP, Bispo FRS, Bonfa ESD de O. Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity [Internet]. Clinical rheumatology. 2022 ; 41( 7): 2079-2089.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1007/s10067-022-06134-x
Artigo de periodico
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)
Aikawa, Nadia Emi; Kupa, Leonard de Vinci Kanda; Medeiros-Ribeiro, Ana Cristina; Saad, Carla Goncalves Schahin; Pereira, Rosa Maria Rodrigues ; Shinjo, Samuel Katsuyuki ; Sartori, Ana Marli Christovam ; Antonangelo, Leila ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, v. 81, n. 7, p. 1036-1043, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-222096. Acesso em: 06 jun. 2024.
APA
Aikawa, N. E., Kupa, L. de V. K., Medeiros-Ribeiro, A. C., Saad, C. G. S., Pereira, R. M. R., Shinjo, S. K., et al. (2022). Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, 81( 7), 1036-1043. doi:10.1136/annrheumdis-2021-222096
NLM
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Vancouver
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Artigo de periodico
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2 (2022)
Shinjo, Samuel Katsuyuki ; Souza, Fernando H. C. de; Borges, Isabela B. P; Santos, Alexandre M. Dos; Miossi, Renata; Misse, Rafael G; Medeiros-Ribeiro, Ana C; Kupa, Leonard de Vinci Kanda ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Rheumatology. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHINJO, Samuel Katsuyuki et al. Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2. Rheumatology, v. 61, n. 8, p. 3351-3361, 2022Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab773. Acesso em: 06 jun. 2024.
APA
Shinjo, S. K., Souza, F. H. C. de, Borges, I. B. P., Santos, A. M. D., Miossi, R., Misse, R. G., et al. (2022). Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2. Rheumatology, 61( 8), 3351-3361. doi:10.1093/rheumatology/keab773
NLM
Shinjo SK, Souza FHC de, Borges IBP, Santos AMD, Miossi R, Misse RG, Medeiros-Ribeiro AC, Kupa L de VK, Silva CAA da, Bonfa ESD de O. Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2 [Internet]. Rheumatology. 2022 ; 61( 8): 3351-3361.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/rheumatology/keab773
Vancouver
Shinjo SK, Souza FHC de, Borges IBP, Santos AMD, Miossi R, Misse RG, Medeiros-Ribeiro AC, Kupa L de VK, Silva CAA da, Bonfa ESD de O. Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2 [Internet]. Rheumatology. 2022 ; 61( 8): 3351-3361.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/rheumatology/keab773
Artigo de periodico
Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review (2022)
Soares Junior, Jose Maria ; Sorpreso, Isabel Cristina Esposito ; Curado, J. F. Nunes; Ferreira Filho, E. S; Simoes, R. dos Santos; Bonfa, Eloisa Silva Dutra de Oliveira ; Silva, Clovis Artur Almeida da ; Baracat, Edmund Chada
Source: Climacteric. Unidade: FM
Subjects: SINAIS E SINTOMAS, MENOPAUSA, LÚPUS ERITEMATOSO SISTÊMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES JUNIOR, Jose Maria et al. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review. Climacteric, v. 25, n. 5, p. 427-433, 2022Tradução . . Disponível em: https://doi.org/10.1080/13697137.2022.2050205. Acesso em: 06 jun. 2024.
APA
Soares Junior, J. M., Sorpreso, I. C. E., Curado, J. F. N., Ferreira Filho, E. S., Simoes, R. dos S., Bonfa, E. S. D. de O., et al. (2022). Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review. Climacteric, 25( 5), 427-433. doi:10.1080/13697137.2022.2050205
NLM
Soares Junior JM, Sorpreso ICE, Curado JFN, Ferreira Filho ES, Simoes R dos S, Bonfa ESD de O, Silva CAA da, Baracat EC. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review [Internet]. Climacteric. 2022 ; 25( 5): 427-433.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1080/13697137.2022.2050205
Vancouver
Soares Junior JM, Sorpreso ICE, Curado JFN, Ferreira Filho ES, Simoes R dos S, Bonfa ESD de O, Silva CAA da, Baracat EC. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review [Internet]. Climacteric. 2022 ; 25( 5): 427-433.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1080/13697137.2022.2050205
Artigo de periodico
VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells (2022)
Cruvinel, Wilson de Melo; Andrade, Luis Eduardo Coelho; Dellavance, Alessandra; Ximenes, Antonio Carlos; Bichara, Carlos David Araujo; Mangueira, Cristovao Luis Pitangueira; Bonfa, Eloisa Silva Dutra de Oliveira ; Brito, Fabiano de Almeida; Mariz, Henrique Ataide; Anjos, Lisiane Maria Enriconi dos
Source: Advances in rheumatology. Unidade: FM
Subjects: ANTICORPOS, SOBREVIDA, CONSENSO, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUVINEL, Wilson de Melo et al. VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells. Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s42358-022-00266-z. Acesso em: 06 jun. 2024.
APA
Cruvinel, W. de M., Andrade, L. E. C., Dellavance, A., Ximenes, A. C., Bichara, C. D. A., Mangueira, C. L. P., et al. (2022). VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells. Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00266-z
NLM
Cruvinel W de M, Andrade LEC, Dellavance A, Ximenes AC, Bichara CDA, Mangueira CLP, Bonfa ESD de O, Brito F de A, Mariz HA, Anjos LME dos. VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s42358-022-00266-z
Vancouver
Cruvinel W de M, Andrade LEC, Dellavance A, Ximenes AC, Bichara CDA, Mangueira CLP, Bonfa ESD de O, Brito F de A, Mariz HA, Anjos LME dos. VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s42358-022-00266-z
Artigo de periodico
Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records (2022)
Rodrigues, Davi Silva ; Nastri, Ana Catharina de Seixas Santos ; Magri, Marcello M.; Oliveira, Maura Salaroli de ; Sabino, Ester Cerdeira ; Figueiredo, Pedro H. M. F.; Levin, Anna Sara ; Freire, Maristela P. ; Harima, Leila; Nunes, Fátima L. S.; Ferreira, João Eduardo ; Busatto, Geraldo ; Bonfa, Eloisa Silva Dutra de Oliveira ; Utiyama, Edivaldo Massazo ; Segurado, Aluisio Augusto Cotrim ; Perondi, Beatriz ; Morais, Anna M.; Montal, Amanda ; Fusco, Solange ; Fregonesi, Marjorie; Rocha, Marcelo; Marcílio, Izabel ; Rios, Izabel C; Kawano, Fabiane Y. O.; de Jesus, M. Amelia; Kallas, Esper Georges ; Marmo, Carolina; Tanaka, Clarice ; Souza, Heraldo Possolo de ; Marchini, Julio Flavio ; Carvalho, Carlos; Ferreira, Juliana C.; Guimarães, Thais ; Lazari, Carolina S.; Duarte, Alberto José da Silva; Francisco, M. Cristina P. B.; Costa, Sílvia Figueiredo
Source: BMC Medical Informatics and Decision Making. Unidades: FM, EACH, IME, FMRP
Subjects: COVID-19, SINAIS VITAIS, ANÁLISE DE SÉRIES TEMPORAIS, COMPUTAÇÃO APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Davi Silva et al. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, v. 22, n. artigo 187, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12911-022-01931-5. Acesso em: 06 jun. 2024.
APA
Rodrigues, D. S., Nastri, A. C. de S. S., Magri, M. M., Oliveira, M. S. de, Sabino, E. C., Figueiredo, P. H. M. F., et al. (2022). Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, 22( artigo 187). doi:10.1186/s12911-022-01931-5
NLM
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Vancouver
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Artigo de periodico
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy (2022)
Sampaio-Barros, Percival Degrava; Medeiros-Ribeiro, Ana Cristina; Luppino-Assad, Ana Paula; Miossi, Renata; Silva, Henrique Carrico da; Yuki, Emily F. V. N; Pasoto, Sandra G; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Rheumatology. Unidade: FM
Subjects: PEDIATRIA, DOENÇAS NEONATAIS E ANORMALIDADES, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO-BARROS, Percival Degrava et al. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy. Rheumatology, v. 61, n. SI2, p. SI169-SI174, 2022Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab886. Acesso em: 06 jun. 2024.
APA
Sampaio-Barros, P. D., Medeiros-Ribeiro, A. C., Luppino-Assad, A. P., Miossi, R., Silva, H. C. da, Yuki, E. F. V. N., et al. (2022). SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy. Rheumatology, 61( SI2), SI169-SI174. doi:10.1093/rheumatology/keab886
NLM
Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Silva HC da, Yuki EFVN, Pasoto SG, Saad CGS, Silva CAA da, Kupa L de VK, Bonfa ESD de O. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy [Internet]. Rheumatology. 2022 ; 61( SI2): SI169-SI174.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/rheumatology/keab886
Vancouver
Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Silva HC da, Yuki EFVN, Pasoto SG, Saad CGS, Silva CAA da, Kupa L de VK, Bonfa ESD de O. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy [Internet]. Rheumatology. 2022 ; 61( SI2): SI169-SI174.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1093/rheumatology/keab886
Artigo de periodico
Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring (2022)
Novellino, Renata Soares; Chalom, Marc Yves; Romano, Paschoalina; Ebner, Persio de Almeida Rezende; Seraphim, Julia Celestino; Amaral, Ana Carolina Silva do; Duarte, Nilo Jose Coelho; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira ; Kupa, Leonard de Vinci Kanda
Source: Bioanalysis. Unidade: FM
Subjects: LÚPUS ERITEMATOSO CUTÂNEO, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVELLINO, Renata Soares et al. Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring. Bioanalysis, v. 14, n. 15, p. 1039-1050, 2022Tradução . . Disponível em: https://doi.org/10.4155/bio-2022-0077. Acesso em: 06 jun. 2024.
APA
Novellino, R. S., Chalom, M. Y., Romano, P., Ebner, P. de A. R., Seraphim, J. C., Amaral, A. C. S. do, et al. (2022). Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring. Bioanalysis, 14( 15), 1039-1050. doi:10.4155/bio-2022-0077
NLM
Novellino RS, Chalom MY, Romano P, Ebner P de AR, Seraphim JC, Amaral ACS do, Duarte NJC, Silva CAA da, Bonfa ESD de O, Kupa L de VK. Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring [Internet]. Bioanalysis. 2022 ; 14( 15): 1039-1050.[citado 2024 jun. 06 ] Available from: https://doi.org/10.4155/bio-2022-0077
Vancouver
Novellino RS, Chalom MY, Romano P, Ebner P de AR, Seraphim JC, Amaral ACS do, Duarte NJC, Silva CAA da, Bonfa ESD de O, Kupa L de VK. Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring [Internet]. Bioanalysis. 2022 ; 14( 15): 1039-1050.[citado 2024 jun. 06 ] Available from: https://doi.org/10.4155/bio-2022-0077
Artigo de periodico
Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up (2020)
Usuba, Fany Solange; Saad, Carla Gonçalves Schahin; Aikawa, Nádia Emi; Novaes, Priscila; Moraes, Julio Cesar Bertacini de; Santo, Ruth Miyuki; Carvalho, Jozélio Freire de; Bonfá, Eloísa; Alves, Milton Ruiz
Source: Scientific Reports. Unidades: HU, FM
Subjects: ESPONDILITE ANQUILOSANTE, OLHO, OFTALMOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
USUBA, Fany Solange et al. Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up. Scientific Reports, v. 10, n. ja 2020, p. 334, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-57266-1. Acesso em: 06 jun. 2024.
APA
Usuba, F. S., Saad, C. G. S., Aikawa, N. E., Novaes, P., Moraes, J. C. B. de, Santo, R. M., et al. (2020). Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up. Scientific Reports, 10( ja 2020), 334. doi:10.1038/s41598-019-57266-1
NLM
Usuba FS, Saad CGS, Aikawa NE, Novaes P, Moraes JCB de, Santo RM, Carvalho JF de, Bonfá E, Alves MR. Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up [Internet]. Scientific Reports. 2020 ; 10( ja 2020): 334.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1038/s41598-019-57266-1
Vancouver
Usuba FS, Saad CGS, Aikawa NE, Novaes P, Moraes JCB de, Santo RM, Carvalho JF de, Bonfá E, Alves MR. Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up [Internet]. Scientific Reports. 2020 ; 10( ja 2020): 334.[citado 2024 jun. 06 ] Available from: https://doi.org/10.1038/s41598-019-57266-1
Artigo de periodico
Sexual function in female juvenile idiopathic arthritis patients (2019)
Pitta, Ana Claudia; Ferreira, Gabriela Ribeiro Viola; Tomioka, Renato Bussadori; Lourenco, Daniela Mencaroni Rodrigues; Kozu, Katia; Aikawa, Nadia Emi; Sallum, Adriana Maluf Elias; Campos, Lucia Maria Arruda; Abdo, Carmita Helena Najjar; Pereira, Rosa Maria Rodrigues
Source: Advances in rheumatology. Unidade: FM
Subjects: ARTRITE REUMATOIDE JUVENIL, DISFUNÇÃO SEXUAL FISIOLÓGICA, MULHERES, ADOLESCENTES, JOVENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PITTA, Ana Claudia et al. Sexual function in female juvenile idiopathic arthritis patients. Advances in rheumatology, v. 59, 2019Tradução . . Disponível em: https://doi.org/10.1186/s42358-019-0058-8. Acesso em: 06 jun. 2024.
APA
Pitta, A. C., Ferreira, G. R. V., Tomioka, R. B., Lourenco, D. M. R., Kozu, K., Aikawa, N. E., et al. (2019). Sexual function in female juvenile idiopathic arthritis patients. Advances in rheumatology, 59. doi:10.1186/s42358-019-0058-8
NLM
Pitta AC, Ferreira GRV, Tomioka RB, Lourenco DMR, Kozu K, Aikawa NE, Sallum AME, Campos LMA, Abdo CHN, Pereira RMR. Sexual function in female juvenile idiopathic arthritis patients [Internet]. Advances in rheumatology. 2019 ; 59[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s42358-019-0058-8
Vancouver
Pitta AC, Ferreira GRV, Tomioka RB, Lourenco DMR, Kozu K, Aikawa NE, Sallum AME, Campos LMA, Abdo CHN, Pereira RMR. Sexual function in female juvenile idiopathic arthritis patients [Internet]. Advances in rheumatology. 2019 ; 59[citado 2024 jun. 06 ] Available from: https://doi.org/10.1186/s42358-019-0058-8

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation